With kidney disease, asking “Can I use a weight injection?” is only a starting point. The diagnosis, current progress, other medicines and care suited to your kidney function all matter. A useful decision combines possible benefits with a clear monitoring plan and instructions for days when eating or drinking becomes difficult.
Health information for general guidance. This content provides general information. It does not replace medical advice, examination, diagnosis or treatment, or individual nutrition advice. Discuss medication decisions with your treating clinician; do not change treatment based on this page. Seek medical help for acute or severe symptoms.
Make the starting findings understandable
Ask which kidney condition has been diagnosed and whether results have been stable over time. Estimated filtering function, eGFR, and albumin in urine are often relevant. Ask what these measurements mean in your circumstances. One result does not provide the whole story. Bring earlier findings if several teams currently hold different parts of your history, and ask which changes are clinically meaningful rather than trying to interpret every fluctuation yourself.
What FLOW actually studied
FLOW studied 3,533 people with type 2 diabetes and chronic kidney disease over a median 3.4 years. The combined endpoint of major kidney events and kidney-related or cardiovascular death occurred less often with semaglutide than placebo.
This does not establish the same benefit for every kidney condition, people without diabetes or any product in the same medicine family. The molecule, studied use and authorisation also need distinguishing. Ask how closely your diagnosis matches the studied situation and which specific treatment goal matters in your case. A favourable headline is not an individual prediction.
Check the product's own information
Requirements and experience in reduced kidney function differ between products and stages of disease. A favourable trial result does not replace checking these details. Ask the prescribing team to compare the current product information with your findings. Kidney disease is neither automatically a universal prohibition nor a blanket reason to prescribe. Dialysis or transplantation calls for particularly specific specialist coordination rather than applying advice intended for a different clinical situation.
Discuss fluid loss early
Nausea, vomiting and diarrhoea can occur with the products concerned. Dehydration can worsen kidney function. Agree in advance whom to contact if you cannot keep fluids down or symptoms persist. Markedly reduced urine, substantial weakness or feeling faint should not wait until a routine review. Simply advising everyone to drink a large amount is not a safe solution when an individual fluid allowance may apply.
Adapt nutrition to your circumstances
Muscle strength and adequate food remain important. Kidney disease may also involve specific advice about protein, salt, certain minerals or fluids. Not everyone needs the same restrictions. Ask a qualified dietitian for a plan that accounts for your diagnosis and any change in the amount you eat. Do not adopt high-protein fitness plans or strict exclusion lists without checking whether they fit your care. Practical meals matter more than competing general rules.
Agree responsibilities and monitoring
Keep all medicines and supplements on one list. Clarify who assesses changes in kidney results, blood pressure or glucose and which team handles questions. Ask for written instructions for acute illness; do not invent your own stopping and restarting plan. Record the next appointment and the results needed for it. Coordination should make decisions clearer, not leave you solely responsible for joining together information from several professionals.
How to get started
- Ask for a clear summary of your kidney findings.
- Agree contacts for vomiting, diarrhoea or difficulty drinking.
- Coordinate nutrition, medicines and monitoring with the relevant professionals.
Common questions
Does a favourable kidney trial mean the medicine will definitely protect my kidneys?
No. An average trial benefit is not an individual guarantee. Diagnosis, other conditions, tolerability and the exact product remain important.
Should I drink more and eat more protein just to be safe?
Not as a general rule. With kidney disease, fluid intake and nutrition need to fit your findings. Ask for individual guidance and a plan for fluid loss.
Sources & further reading
- Perkovic et al. (2024): Semaglutide in type 2 diabetes and chronic kidney disease – FLOW
- KDIGO: 2024 clinical practice guideline for chronic kidney disease
- EMA: Wegovy – current EU product information
- EMA: Mounjaro – current EU product information
Sources checked:





Questions and experiences
Share a question or a useful experience about this topic. Every contribution is checked before publication. Comments may be written in different languages.
Loading reader contributions…
Opening the form sets a necessary session cookie. No email address is required. Publication is subject to moderation and is not guaranteed. For deletion requests: Contact